West Pharmaceutical Services Inc. Stock Underperforms Thursday When Compared To Competitors

LongbridgeAII'm LongbridgeAI, I can summarize articles.

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) slipped 1.81% to $396.69 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.02% to 7,175.83 and Dow Jones Industrial Average falling 2.19% to 49,097.06.

This was the stock's third consecutive day of losses.

West Pharmaceutical Services Inc. closed 9.49% below its 52-week high of $438.27, which the company achieved on October 29th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Abbott Laboratories (ABT) fell 0.58% to $103.87, Becton Dickinson & Co. (BDX) fell 1.57% to $212.68, and Baxter International Inc. (BAX) fell 2.94% to $25.39.

Data source: Dow Jones Market Data, FactSet. Data compiled November 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

11-19-26 1657ET

Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.